» Articles » PMID: 29275810

Necrotizing Enterocolitis: Pathophysiology from a Historical Context

Overview
Specialty Pediatrics
Date 2017 Dec 26
PMID 29275810
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Necrotizing enterocolitis (NEC) continues to afflict approximately 7% of preterm infants born weighing less than 1500g, though recent investigations have provided novel insights into the pathogenesis of this complex disease. The disease has been a major cause of morbidity and mortality in neonatal intensive care units worldwide for many years, and our current understanding reflects exceptional observations made decades ago. In this review, we will describe NEC from a historical context and summarize seminal findings that underscore the importance of enteral feeding, the gut microbiota, and intestinal inflammation in this complex pathophysiology.

Citing Articles

A Phosphodiesterase Type-5 (PDE-5) Inhibitor, Sildenafil, Ameliorates the NEC Induced Inflammation.

Ovali M, Oztopuz O, Karaboga I Protein J. 2025; .

PMID: 40056331 DOI: 10.1007/s10930-025-10263-y.


Optimizing nutritional strategies in term NEC and perforation infants after intestinal operation: a retrospective study.

Luo W, Cao H, Hu Y, Liu Z, Yang J, Deng P Sci Rep. 2025; 15(1):5577.

PMID: 39955353 PMC: 11829962. DOI: 10.1038/s41598-025-90366-9.


Struggling to Understand the NEC Spectrum-Could the Integration of Metabolomics, Clinical-Laboratory Data, and Other Emerging Technologies Help Diagnosis?.

Sarafidis K, Agakidou E, Kontou A, Agakidis C, Neu J Metabolites. 2024; 14(10).

PMID: 39452903 PMC: 11509608. DOI: 10.3390/metabo14100521.


Value of portal venous gas and a nomogram for predicting severe neonatal necrotizing enterocolitis.

Chen Y, Duan Y, Wei B, Jiang Y, Tan Y, Wei Y Pediatr Res. 2024; .

PMID: 39341944 DOI: 10.1038/s41390-024-03605-6.


Risk factors for necrotizing enterocolitis in small-for-gestational-age infants: a matched case-control study.

Ding X, Hu X, Chen S, Guo L, Wang Z, He Y Sci Rep. 2024; 14(1):19098.

PMID: 39154081 PMC: 11330453. DOI: 10.1038/s41598-024-70351-4.


References
1.
Good M, Siggers R, Sodhi C, Afrazi A, Alkhudari F, Egan C . Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A. 2012; 109(28):11330-5. PMC: 3396489. DOI: 10.1073/pnas.1200856109. View

2.
Sodhi C, Shi X, Richardson W, Grant Z, Shapiro R, Prindle Jr T . Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology. 2009; 138(1):185-96. PMC: 2813409. DOI: 10.1053/j.gastro.2009.09.045. View

3.
STEIN H, Beck J, Solomon A, SCHMAMAN A . Gastroenteritis with necrotizing enterocolitis in premature babies. Br Med J. 1972; 2(5814):616-9. PMC: 1788389. DOI: 10.1136/bmj.2.5814.616. View

4.
Leaphart C, Cavallo J, Gribar S, Cetin S, Li J, Branca M . A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007; 179(7):4808-20. DOI: 10.4049/jimmunol.179.7.4808. View

5.
Wipf P, Eyer B, Yamaguchi Y, Zhang F, Neal M, Sodhi C . Synthesis of -inflammatory α-and β-linked acetamidopyranosides as inhibitors of toll-like receptor 4 (TLR4). Tetrahedron Lett. 2015; 56(23):3097-3100. PMC: 4518473. DOI: 10.1016/j.tetlet.2014.11.048. View